© 2023 MJH Life Sciences and Nutritional Outlook. All rights reserved.
© 2023 MJH Life Sciences™ and Nutritional Outlook. All rights reserved.
January 27, 2023
CBD is an established product that is paving the way for other hemp-derived cannabinoids. However, regulation remains a big if for the category.
Brinckmann will serve as the president of the board of trustees for the nonprofit research and education organization the American Botanical Council.
January 26, 2023
The U.S. Food and Drug Administration has reached the conclusion that “a new regulatory pathway for CBD is needed that balances individuals’ desire for access to CBD products with the regulatory oversight needed to manage risks.”
BioActor develops clinically evaluated polyphenol extracts from edible plants and fruits.
January 25, 2023
Dentali will consult Nammex on further best practices for the mushroom market.
January 23, 2023
Ashwagandha saw incremental sales gains in 2022.
January 19, 2023
Dowling will provide Nutritional Outlook’s editors with key guidance and insights on the hemp-derived-CBD product market.
January 18, 2023
David Murray, the director of the Office of Disease Prevention at the National Institutes of Health, is currently serving as the acting director of the Office of Dietary Supplements (ODS) until a new, permanent ODS director is selected.
January 17, 2023
Nutritional Outlook’s Editorial Advisory Board shares its predictions and tips for success in 2023.
Results showed that, compared to placebo, subjects taking the black seed and astaxanthin blend reported significantly fewer upper-respiratory tract complaints and better overall well-being, as well as lower cortisol and superior microbiome indices.